MAPK3 and breast cancer: In recent years, clinical studies have shown that these screened gene biomarkers, namely MAPK 1 [75,76,77,78,79,80], APOBEC3B [81,82,83,84], and ENAH [85,86,87,88], are known to be related to the pathophysiology of BC.